Cargando…
EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers
The presence of the Epstein-Barr virus (EBV)-encoded nuclear antigen-1 (EBNA1) protein in all EBV-carrying tumours constitutes a marker that distinguishes the virus-associated cancer cells from normal cells and thereby offers opportunities for targeted therapeutic intervention. EBNA1 is essential fo...
Autores principales: | Wilson, Joanna B., Manet, Evelyne, Gruffat, Henri, Busson, Pierre, Blondel, Marc, Fahraeus, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923364/ https://www.ncbi.nlm.nih.gov/pubmed/29642420 http://dx.doi.org/10.3390/cancers10040109 |
Ejemplares similares
-
Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA
por: Lista, María José, et al.
Publicado: (2017) -
Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein
por: Manet, Evelyne, et al.
Publicado: (2021) -
The Epstein-Barr Virus EBNA1 Protein
por: Frappier, Lori
Publicado: (2012) -
Epstein-Barr Virus Down-Regulates Tumor Suppressor DOK1 Expression
por: Siouda, Maha, et al.
Publicado: (2014) -
Translation of intronless RNAs is strongly stimulated by the Epstein–Barr virus mRNA export factor EB2
por: Ricci, Emiliano P., et al.
Publicado: (2009)